Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
23 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR ANTOINE ADAM-TESSIER
1 BIS RUE DES ABBESSES, 75018 PARIS
CDS MEDICAL ARTHUR VERNES
36 R D ASSAS, 75006 PARIS
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The journal of applied laboratory medicine · 2026
Abstract Background The diagnosis of laryngopharyngeal reflux disease (LPRD) mostly uses invasive techniques. Our aim was to carry out a performance study of noninvasive saliva biomarkers in LPRD patients and to investigate clinical utility. Methods The saliva of 201 patients with an LPRD diagnosis was prospectively collected using a Salivette® device. Findings were compared with 35 healthy controls using nonparametric statistics. Biomarker cut-offs were determined with receiver operating curves (ROCs). Results The analytical performance study indicated satisfactory performance against biological acceptability goals for bias, imprecision, and total allowable error. The limit of detection (LOD) was evaluated for all biomarkers in the saliva matrix. Results fell within the analytical measurement range for salivary elastase, trypsin, and pH and close to the LOD for cholesterol. The clinical study reported significantly higher salivary pH and elastase and lower cholesterol in LPRD compared to controls (P < 0.05), while salivary trypsin did not differ significantly. Diagnostic cut-offs determined with ROC were salivary elastase >49 µg/mL, salivary pH >7.6, and salivary cholesterol <2.1 mg/dL (<0.054 mmol/L). The combination of salivary elastase with cholesterol gave a positive predictive value of 93% and a negative predictive value of 100% for the diagnosis of LPRD in this study. Salivary total bilirubin, lipase, and pepsin were mostly undetected. Conclusions Noninvasive diagnosis of LPRD is possible, based on a single saliva collection, although our cut-offs should be evaluated in further studies. A reproducible analytical protocol has been obtained. Salivary elastase, cholesterol, and pH show clinical utility for the presence of duodeno-gastric reflux in LPRD patients.
Cancer medicine · 2026
ABSTRACT Background Emotional regulation (ER) is crucial for the psychological well‐being of patients with cancer and their relatives. Various ER interventions exist but often suffer from poor adherence and high attrition rates. Aims This systematic review aims to identify ER interventions for patients with cancer and their relatives, describe their content, development, and evaluation methods, and assess their efficacy on ER and psychological health outcomes. Methods Cochrane, Embase, PsycArticles, PsycINFO, and Web of Science databases were searched. Eligible studies examined individual interventions targeting ER (Intervention) in adult patients with cancer and their relatives (Population), included a control group or a pre–post assessment (Comparator), and reported outcomes related to ER or psychological health outcomes using quantitative or mixed‐method results (Study type). Results Eight studies were included. Most interventions were theoretically grounded in cognitive behavioral therapy (CBT) and followed a similar structure: informational sessions, skill‐building modules using targeted therapeutic techniques, and consolidation via homework and relapse‐prevention exercises. Despite high attrition rates, most interventions significantly improved ER and psychological outcomes. Some trials lacked statistical significance, mainly due to methodological limitations. Although acceptability was rarely assessed, evidence suggests patient–relatives dyadic approaches may better meet participant needs. Conclusion ER interventions share common features and show effectiveness but sometimes lack alignment between objectives and evaluated outcomes. Retention remains a major challenge, emphasizing the need to redesign interventions and their implementation. Future research should explore attrition causes and develop strategies to enhance engagement.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
International journal of implant dentistry · 2026 · Journal Article
Gabriel T, Constance C, Anissa Z, Théo P, et al.
Kidney international · 2026 · Case Reports
Tom M, Iulia H, Sophie PM, Antoine D
JAMA network open · 2026 · Journal Article
Zamarripa CA, Lin S, Klausner M, Rastogi K, et al.
Nature communications · 2026 · Journal Article
Edoo Z, Grosse C, Maitre T, Frita R, et al.
JHEP reports : innovation in hepatology · 2026 · Journal Article
Meszaros M, Ursic-Bedoya J, Coilly A, Francoz C, et al.
The journal of applied laboratory medicine · 2026 · Journal Article
De Vos NV, Trelcat A, Antoine M, Dahma H, et al.
Journal of public health management and practice : JPHMP · 2026 · Journal Article
Antoine M, Ojo AI, Bertulfo MC, Okomo-Adhiambo M, et al.
Clinical transplantation · 2026 · Journal Article
Andreassian M, Gaudez F, Desgrandchamps F, Masson-Lecomte A, et al.
Journal of orthopaedic case reports · 2026 · Case Reports
Vlad B, Stefano P, Antoine DP, Nathan L, et al.
Journal of Parkinson's disease · 2026 · Journal Article
Dujardin K, Manceau C, Wawrziczny E, Flinois B, et al.
Communications medicine · 2026 · Published Erratum
Ousdal OT, Argyelan M, Laroy M, Anand A, et al.
Frontiers in pharmacology · 2025 · Journal Article
Cubilier E, Taghavi M, De Prez E, Jacobs L, et al.
Journal of geriatric oncology · 2026 · Journal Article
Rolland C, Leguelinel-Blache G, Cireaşă B, Cousin C, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
Toxins · 2026 · Journal Article
Kaysi S, Taghavi M, El Mourabi A, Antoine MH, et al.
Journal of geriatric oncology · 2026 · Journal Article
Rolland C, Leguelinel-Blache G, Cireaşă B, Cousin C, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
Cancer medicine · 2026 · Journal Article
Naeyaert A, Fournier V, Caton L, Gandolphe MC, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
European journal of cancer (Oxford, England : 1990) · 2026 · Published Erratum
Salomé V, Antoine J, Côme L, Pierre G, et al.
Neurocritical care · 2026 · Journal Article
Dakeng M, Antoine P, Velly L, Oujamaa L, et al.
JCI insight · 2026 · Journal Article
Antonello PC, Hodgkinson CA, Feng D, Marietta C, et al.
Neurology · 2026 · Journal Article
Jacobs BM, Schalk L, Tregaskis-Daniels E, Scalfari A, et al.
Journal of geriatric oncology · 2026 · Journal Article
Rolland C, Leguelinel-Blache G, Cireaşă B, Cousin C, et al.
Geriatric nursing (New York, N.Y.) · 2026 · Journal Article
Gallouj K, Antoine P, Chapelet G, El Haj M
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Xin P, Li W, A X, Shen J, et al.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026 · Journal Article
Zalcman G, Madroszyk A, Guenzi E, Dayen C, et al.
Cancer medicine · 2026 · Journal Article
Naeyaert A, Fournier V, Caton L, Gandolphe MC, et al.